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Human mesenchymal stem/stromal cells (MSCs) have received considerable attention in
the field of cell-based therapies due to their high differentiation potential and ability to mod-
ulate immune responses. However, since these cells can only be isolated in very low quanti-
ties, successful realization of these therapies requires MSCs ex-vivo expansion to achieve
relevant cell doses. The metabolic activity is one of the parameters often monitored during
MSCs cultivation by using expensive multi-analytical methods, some of them time-
consuming. The present work evaluates the use of mid-infrared (MIR) spectroscopy, through
rapid and economic high-throughput analyses associated to multivariate data analysis, to
monitor three different MSCs cultivation runs conducted in spinner flasks, under xeno-free
culture conditions, which differ in the type of microcarriers used and the culture feeding
strategy applied. After evaluating diverse spectral preprocessing techniques, the optimized
partial least square (PLS) regression models based on the MIR spectra to estimate the glu-
cose, lactate and ammonia concentrations yielded high coefficients of determination
(R2 0.98, 0.98, and 0.94, respectively) and low prediction errors (RMSECV 4.7%,
4.4% and 5.7%, respectively). Besides PLS models valid for specific expansion protocols,
a robust model simultaneously valid for the three processes was also built for predicting glu-
cose, lactate and ammonia, yielding a R2 of 0.95, 0.97 and 0.86, and a RMSECV of 0.33,
0.57, and 0.09 mM, respectively. Therefore, MIR spectroscopy combined with multivariate
data analysis represents a promising tool for both optimization and control of MSCs expan-
sion processes. VC 2015 American Institute of Chemical Engineers Biotechnol. Prog.,
000:000–000, 2015
Keywords: mesenchymal stem/stromal cells, MIR spectroscopy, high-throughput analysis
Introduction
Human mesenchymal stem/stromal cells (MSCs) have
been widely studied for applications in regenerative medicine
settings due to their ability to differentiate into diverse cell
types, to produce trophic, paracrine and immunomodulatory
factors, and to migrate towards sites of injured tissue, inflam-
matory and tumor sites.1–3 MSCs have been isolated from
tissues of perinatal origin (e.g., umbilical cord and placenta)
and adult tissues like bone marrow (BM) and adipose tissue,4
being able to differentiate into cell types of mesodermal
origin (cartilage, bone, fat, among others).5 Under specific
conditions, MSCs also secrete bioactive molecules like cyto-
kines, specific growth factors and antioxidants, which may
act as immunomodulatory and promote tissue regeneration.
To explore the intrinsic trophic activity of MSCs, the admin-
istration of these cells has been studied in numerous clinical
trials, namely for knee cartilage injuries, Crohn’s disease,
acute respiratory distress syndrome, multiple sclerosis, limb
and foot ischemia in diabetic patients, osteoarthrites, ulcera-
tive colitis, and graft-vs.-host disease (http://clinicaltrials.gov
accessed in Mars 2015).
Despite their great potential, MSCs are considerably rare
in the human organism, representing, for instance, 0.001–
0.01% of the mononuclear cells in BM. Considering that
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average clinical doses are typically above 1 million MSCs
per kg of patient body weight,6 the expansion process of this
type of cells represents an essential step for the translation
of MSCs therapeutic potential.
To date, clinical-scale expansion of MSCs, which are
anchorage dependent, has been performed in multilayer pla-
nar culture systems in the presence of fetal bovine serum
(FBS) or human-sourced supplements, which present serious
limitations of scalability and standardization, and are associ-
ated with safety risks and high labor costs.7 Stirred bioreac-
tors, combined with cell immobilization onto microcarriers,
offer significant advantages over static systems, as they pro-
vide a homogeneous culture environment, monitoring and
control procedures of key culture parameters and easy scal-
ability.8–10 Additionally, the use of well-defined xenogeneic
(xeno)-free materials and formulations is essential for meet-
ing rigorous quality and regulatory standards to robustly gen-
erate clinical-grade cells.11 Overall MSC manufacturing
depends on both biological and bioprocessing factors namely
age and condition of the donor, cell source and isolation
techniques used,12,13 as well as on culture operation parame-
ters (agitation, dissolved oxygen) and conditions (culture
medium, surface coating, microcarrier type).14,15 As small
variations in the expansion process can cause serious
changes in the MSCs final quality, a reproducible process
and consequently an effective therapeutic product will only
be ensured if appropriate monitoring and control of the
MSCs expansion process is adopted.
Some of the variables that are commonly monitored in
mammalian cell cultures include pH, temperature, dissolved
oxygen concentration (DOC), and key analytes of cell
metabolism like glucose, lactate, and ammonia.16 Sensors for
online monitoring of temperature, pH and DOC are well
established. However, monitoring of the remaining critical
variables of this bioprocess usually rely on multiple techni-
ques, such as enzymatic assays, high-performance liquid
chromatography and immuno-assays,17 some of them based
on time-consuming procedures. It is therefore critical to
develop a new rapid and sensitive technique that enables the
simultaneous acquisition of information concerning the criti-
cal variables of a given process (for control purposes) or
multiple processes (for optimization purposes) and the whole
molecular fingerprint of the complex culture matrices. In the
spectroscopic field, vibrational spectroscopy such as Fourier
transform infrared (FTIR) and Raman spectroscopies are
able to detect the vibrational modes of biomolecules, thus
holding the promise of playing an important role on the
development of such ideal monitoring technique.
Vibrational spectroscopy detects the overall sample molec-
ular fingerprint in a highly sensitive, rapid and economic
way.16–32 The technique does not require the use of any
reagents or sample complex processing and a spectrum can
be acquired in a time frame of a minute. Furthermore, the
technique associated to multivariate analysis, e.g. partial
least square (PLS) regression, allows the rapid quantification
of several critical process variables from a single spectrum
(i.e. the technique is multiparametric), in a highly sensitive
way compared to conventional methods.18–20 (Table 1).
The interest of monitoring animal cell cultures using
vibrational spectroscopy is currently on its early stages.
FTIR spectroscopy can be operated in the mid-infrared
(MIR) and near-infrared (NIR) regions of the electromag-
netic spectrum. Both MIR and NIR spectroscopies combined
with PLS regression have been used to predict diverse
metabolite concentrations in cultures of Chinese hamster
ovary (CHO) cell lines, human embryonic kidney (HEK) cell
lines, PC3 prostate cancer cells and Vero cell
lines.16,18–20,27–30 However, the errors of prediction obtained
from these researchers are not fully comparable, as different
cell lines, medium composition, bioreactor design, culture
strategies, and spectral regions were used. To overcome this
issue, Sandor et al.18 compared the NIR and MIR spectral
modes of acquisition combined with PLS regression to pre-
dict glucose on cultures of CHO cell lines, and found more
than 50% error reduction with the MIR in relation to the
NIR spectroscopy setup. This may result from the fact that
the MIR region (between 4000 and 400 cm21) covers the
fundamental vibrations of most common chemical bonds in
biomolecules, where the known fingerprint region (bellow
1500 cm21) arises from the molecular skeleton (e.g., CC,
COC, and COO), whereas the NIR region (between 14,000
and 4000 cm21) covers a more limited diversity of func-
tional groups of biomolecules, detecting almost exclusively
overtones and combination bands of the fundamental vibra-
tions of groups containing the hydrogen atom (CH, NH, OH,
and SH). Besides this advantage, MIR spectroscopy offers
the possibility of high-throughput analysis, using microplates
with multi-wells,31,32 which could speed-up and promote
optimization protocols of MSCs expansion processes, such
as screening for optimal medium composition, initial cell
densities, as well as evaluating the impact of scaling-up on
cell features and final yield (Table 1).
Raman spectroscopy has also been successful applied for
multi-analyte monitoring in mammalian cell cultures (e.g.,
Refs. 33–35). The main advantage over the above infrared
techniques is the weaker absorption of water. However, in
general, high concentrations of the target compounds are
required to yield a detectable scattering, given the low prob-
ability of a molecule to undergo a Raman state transition.
Moreover, at some wavelength ranges fluorescence of bio-
logical compounds present in the culture bulk may be gener-
ated which, being much more intense than Raman scattering,
Table 1. Advantages and Limitations of High-throughput MIR Spectroscopic Methods Compared with Traditional Methods
MIR Spectroscopy Traditional Methods
Reagents need No Yes (e.g., eluents for chromatographic methods,
enzymes and other reagents for enzymatic
analysis)
Cost Low Medium to high
Sample processing before analysis Simple (centrifugation and dehydratation) Simple to complex
Speed of analysis High (1 spectrum per min) Low to medium
Automation Yes Yes or No (depending on the method)
Sample quantity 3–25 lL (depending of the microplate used) Variable (depending on the method)
Type of analysis Multiparametric Uni or multiparametric
Methods for quantitative analysis Multivariate data analysis Univariate data analysis (usually)
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dampens the measurements.36 Indeed, PLS models to predict
glucose, lactate and urea mixtures based on NIR spectra out-
performed the equivalent regression models derived from
Raman spectra.37
The present work evaluates the potential of high-
throughput MIR spectroscopy to monitor the expansion pro-
cess of human MSCs cultured in spinner flasks under xeno-
free culture conditions with different microcarriers and using
different feeding regimes. PLS regression models were
developed to quantitatively predict the consumption of glu-




Human BM-derived MSCs were recovered from cryopre-
servation (as described in dos Santos et al.38) and cultured in
culture flasks with StemPro
VR
MSC SFM XenoFree medium
(Life Technologies), supplemented with Penicillin (at a con-
centration of 0.025 U mL21) and Streptomycin (at a concen-
tration of 0.025 mg mL21) (PenStrep, Life Technologies) and
with GlutaMAXTM-I CTSTM (Life Technologies) as a gluta-
mine substitute. Cells were plated on T-flasks (Corning
Falcon
VR
) at an initial cell density between 3000 and 6000
and incubated at 378C, 5%, in a humidified atmosphere. Cul-
ture medium was renewed every 3 or 4 days. When about 70
or 80% confluence was reached cells were detached with
TrypLETM Select (Life Technologies). Cells were then
seeded and expanded during 13 days on plastic microcarriers
under dynamic conditions, using Bellco
VR
spinner flasks
(Bellco Glass, Inc.) with a working volume of 80 mL,
equipped with 908 paddles and a magnetic stirring bar. Three
different MSCs expansion processes were implemented:
Culture S, using plastic microcarriers (Pall SoloHill) previ-
ously coated with CELLstartTM CTSTM (Life Technologies)
and Culture A1 and A2, using Synthemax
VR
II microcarriers
(Corning). These cultures were initiated with half the final
volume (40 mL), which was then completed on the 3rd day,
after which 25% of the medium was renewed every day for
cultures S and A1 and every 2 days for culture A2.
Reference analysis
Samples were collected from cultures every day (with
exception of day 2), being classified as before and after, if
taken before or after the medium renewal, respectively.
Glucose, lactate and ammonia concentrations were deter-
mined using an automatic enzymatic analyzer YSI7100MBS
(Yellow Springs Instruments).
Cell growth was monitored by harvesting the cells from
the microcarriers with TrypLE solution in a Thermomixer
comfort (Eppendorf) for 7 or 8 min at 378C and 750 rpm.
Then, IMDM with 10% fetal bovine serum (FBS) was added
in a proportion of 1:3. Cells were separated from the micro-
carriers through filtration with a cell strainer (100 lm). Cell
number and viability was determined by Trypan Blue exclu-
sion method (Gibco).
Spectral acquisition
Supernatant samples of the cultures, preserved at 2808C,
were thawed at room temperature and triplicates of 25 mL of
each sample were transferred to a 96-wells Si plate for the
FT-MIR high-throughput measurements. Samples were dehy-
drated before spectral acquisition in a desiccator under vac-
uum. The spectral data were collected using a FTIR Vertex
70 spectrometer (Burker, Germany) equipped with an HTS-
XT accessory (Bruker, Germany). Forty scans in transmis-
sion mode, with a 4 cm21 resolution, were collected in the
wavenumber region between 500 and 4000 cm21. Each spec-
trum was baseline corrected with the OPUS software
(Bruker, Germany) prior to data analysis.
Spectral data analysis
Data preprocessing, including multiplicative scatter cor-
rection (MSC), first and second order derivatives, was
applied to spectral data prior to PLS modeling for predict-
ing glucose, lactate and ammonia concentrations. Deriva-
tives were computed using the Savitzky-Golay algorithm,
with a filter window of 15 data points and a 2nd order
polynomial fit. The performance of the PLS models was
accessed through the evaluation of the root mean square
error of cross-validation (RMSECV), root mean square
error of prediction (RMSEP), the coefficient of determina-
tion (R2) and the error as percentage of the concentration
range (ER%), given by:




The best PLS model was selected regarding a high R2,
low calibration, validation and prediction errors and a low
number of latent variables (LV) covering enough data var-
iance. All calculations were performed using Matlab R2012b
(Matworks, Natick, MA).
Results and Discussion
The expansion of MSCs requires not only the optimization
of the culture general conditions but also the development of
new monitoring methods that can offer sensitive, robust,
rapid and economic monitoring of the expansion process for
control purposes. One example of the critical relevance of
controlling the MSCs expansion process is the high sensitiv-
ity of MSCs to their environment. It has been reported that a
glycolytic metabolism, obtained e.g. at low oxygen tensions
and leading to accumulation of lactate, is associated to pro-
liferation of stem and progenitors cells, including human
MSCs, whereas the predominance of an oxidative phospho-
rylation under higher oxygen tensions is associated to stem
cell differentiation.39 Monitoring cell metabolism in MSCs
cultures is thus of major importance towards the maximiza-
tion of cell yield, while maintaining the intrinsic cell thera-
peutic features.
The effect of different parameters that are critical for
microcarrier-based stirred cultures was evaluated in three dif-
ferent expansion cultures, using different microcarriers and
feeding regimes: Culture S, using SoloHill plastic microcar-
riers which are manually precoated with a xeno-free attach-
ment substrate prior to cell culture and Culture A1 and A2,
using ready-to-use SynthemaxVR II microcarriers (peptide-con-
jugated plastic microcarriers); in culture S and A1, 25% of
the medium was renewed every day after the 3rd day,
whereas in Culture A2, 25% of the medium was renewed
every 2 days (Figure 1). Microcarrier properties can influ-
ence the expansion process and thus, they must allow
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efficient MSCs adhesion and subsequent expansion. In gen-
eral, Cultures S and A1, in which different microcarriers
were used and the medium was renewed every day, exhib-
ited similar glucose and metabolites profiles, with slightly
higher lactate production and glucose consumption in culture
S in the first days (Figure 1). However, this difference was
not associated to relevant distinction in cell growth between
both cultures (Figure 2). Culture A2 presented lower concen-
trations of glucose and higher concentrations of lactate and
ammonia in relation to the other two cultures, as expected
by the less frequent feeding regime (Figure 1). All cultures
were characterized by higher specific glucose consumption
and lactate production in the first days of culture, reaching
maximum values in the fourth or fifth day that decreased
from then on (data not shown); a metabolic profile that has
been previously verified in other works of microcarrier-based
MSCs cultures.40 These values correspond to apparent yields
of lactate from glucose around 2.06 0.2 in the first 5 days
of culture and 1.66 0.2 in the following days, suggesting a
shift to a metabolism where glucose was more efficiently
consumed for energy production.
The three independent cultures presented similar growth
profiles until the sixth day of culture, presenting a lag phase
until the fifth day (Figure 2). From then on, Cultures S and
A1, with daily medium renewal, showed identical growth
profiles, reaching higher cell densities than culture A2,
around 2 3 105 cells mL21. The lower productivity in
Culture A2 until the 8th day may be due to the limitation of
growth factor(s) or nutrient starvation, other than glucose, as
according to the glucose concentration profile, about 3 mM
of glucose was still present when growth started to be com-
promised. On the other hand, lactate and ammonia at this
time point were at non-inhibitory levels (Figures 1B,C).
Overall, in all cultures, regardless the feeding regimen, glu-
cose starvation occurs from day 9 to 10 onwards suggesting
that during that period the levels of this nutrient were limited
for cell growth/maintenance. According to the lactate and
ammonia concentration profiles, slightly higher concentra-
tions of these by-products were reached in Culture A2.
Growth inhibitory concentrations have been reported to be
35.4 mM for lactate and 2.4 mM for ammonia.41 Although
lactate did not reach such inhibitory level, cells seem to
have increased ammonia production after glucose depletion,
reaching inhibitory values (2.7 mM) at the end of culture.
Furthermore, after the 9th day, all cultures started to form
cell-carrier aggregates due to a great level of confluence on
the beads surface, which became larger with time, particu-
larly in cultures S and A1 that achieved higher cell densities
(data not shown). Importantly, after spinner flask cultures,
we verified that expanded MSCs retained their immunophe-
notype and multilineage differentiation capacity (data not
shown), as previously reported by our group.40,42
PLS regression models were developed to estimate glu-
cose, lactate and ammonia concentrations from the MIR
spectra for each of the three cultures (Table 2). PLS ena-
bles predicting a set of dependent variables (e.g. the con-
centration of glucose) from a very large set of independent
variables or predictors (e.g., MIR wavenumbers), by
extracting a set of orthogonal factors from the predictors
designated by latent variables (LV) which have the best
Figure 1. Glucose, lactate and ammonia concentration
throughout BM-MSC expansion in spinner flask




A1 and A2), with medium renewal everyday (cul-
ture S and A1) or every 2 days (culture A2) after
the 3rd day.
Figure 2. Concentration of BM-MSC in xeno-free spinner flask
cultures with pre-coated SoloHill microcarriers (cul-
ture S) and Synthemax II microcarriers (culture A1
and A2). Culture medium was renewed every day
(culture S and A1) or every 2 days (culture A2) after
3rd day of culture. Standard deviation (SD) values
are represented along with the mean values of two
replicate countins for each time point (1 donor).
Table 2. PLS Regression Models Based on Spectral Data Prepro-
cessed with Different Techniques, for the Glucose Prediction During
MSC Cultures Conducted on Pre-coated SoloHill Microcarriers with
the Media Renewed Every Day (Culture S) (MSC—Multiplicative
Scatter Correction)
Without
Preprocessing MSC 1st derivative 2nd derivative
LV R2 RMSECV R2 RMSECV R2 RMSECV R2 RMSECV
2 0.79 0.70 0.81 0.66 0.95 0.34 0.95 0.34
3 0.92 0.43 0.94 0.37 0.97 0.26 0.96 0.31
4 0.94 0.36 0.95 0.32 0.98 0.22 0.98 0.23
5 0.96 0.32 0.96 0.32 0.99 0.18 0.98 0.19
6 0.96 0.29 0.97 0.25 0.99 0.18 0.99 0.18
7 0.97 0.28 0.98 0.23 0.99 0.17 0.99 0.15
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predictive power.43 As each culture presented a low number
of samples (up to 68 for each culture, including the three
replicates for each sample), a leave-one-out (LOO) cross-
validation strategy was applied. To enhance the predictive
ability of the PLS models, the spectral preprocessing tech-
niques MSC and spectral derivatives were evaluated. MSC
can theoretically minimize physical effects, such as light
scattering resulting from particles of different sizes,44
which could appear during the cell pellet dehydration pro-
cess conducted before spectral acquisition. Derivatives can
enhance the information in data, due to increased resolution
of bands overlapping, while minimizing physical interfer-
ences. However, two major drawbacks of applying deriva-
tives are the reduction of the signal scale and noise
amplification. To minimize noise amplification the spectrum
was smoothed with a Savitzky–Golay filter. Table 2 sum-
marizes the performance of PLS models built to estimate
the glucose concentration on culture S, after preprocessing
with MSC and first and second derivatives. The application
of MSC resulted in models with improved performance in
relation to models build without that preprocessing tech-
nique. The application of first derivative also improved the
models performance, while the application of the second
derivative did not significantly improve the models’ predic-
tive ability compared to the application of the first deriva-
tive. The same has been observed for the lactate and
ammonia PLS models, so that the first derivative was
selected as the preprocessing method of choice.
Table 3. PLS Regression Models for Glucose, Lactate, and Ammonia Concentration Prediction, Using the First Derivative as Spectral Prepro-
cessing, for MSC Cultured on Precoated SoloHill Microcarriers (Culture S) or on SynthemaxVR II Microcarriers (Culture A1 and A2), with
Daily Media Renewal (Culture S and A1) or Every 2 Days (Culture A2)
Culture Analyte LV R2 RMSECV Concentration range (mM) Error as % of the concentration range
S Glucose 4 0.98 0.22 0.01–4.61 4.7
Lactate 4 0.98 0.36 1.39–9.65 4.4
Ammonia 5 0.95 0.06 1.29–2.33 5.7
A1 Glucose 4 0.98 0.23 0.00–5.54 4.2
Lactate 5 0.98 0.39 0.02–9.24 4.3
Ammonia 5 0.94 0.06 1.09–2.27 5.4
A2 Glucose 3 0.99 0.17 0.01–5.54 3.2
Lactate 3 0.99 0.25 0.02–9.68 2.5
Ammonia 4 0.94 0.09 1.09–2.67 5.7
Figure 3. Regression vector from the best PLS model built for glucose, lactate and ammonia on cultures of BM-MSC conducted on
pre-coated SoloHill microcarriers (culture S) or on SynthemaxVR II microcarriers (culture A1 and A2), with daily media
renewal (culture S and A1) or every 2 days (culture A2).
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Besides a high R2 and a low error (e.g., RMSECV), a PLS
model should also be based on low number of LV, covering
enough data variance.36,45 A low number of LVs can result
in underfitting especially if the variance represented in data
is low, while a high number can lead to overfitting, which
means reduced model predictive ability outside the condi-
tions used for calibration. A high-accuracy PLS model was
built to predict the glucose concentration during culture S,
using 4 LVs explaining 98% of data variance, and yielding a
R2 of 0.98 and a RMSECV of 0.22 mM. This error is lower
than those obtained by other authors developing of PLS
models for estimating the glucose concentration in mamma-
lian cultures based on MIR spectra obtained either from an
ATR MIR probe or a 96-wells Si plate, producing errors
between 0.5 and 2.17 mM.16,18,19 High-accuracy PLS models
to predict lactate and ammonia concentrations were also
obtained for culture S, considering 4 and 5 LVs explaining
98 and 95% of data variance, yielding a R2 of 0.98 and 0.95
and RMSECV of 0.36 and 0.06 mM, respectively (Table 2).
Previous works on the development of PLS models based on
MIR spectra to predict the lactate concentrations based on
MIR spectra, produced higher errors of prediction, i.e.,
0.6 mM.16,18,19,46
PLS models built for the three analytes for culture A1
yielded very similar results as the models built for culture S,
whereas PLS models built for culture A2 presented slightly
better performances to predict glucose and lactate concentra-
tion and slightly worse to predict the ammonia concentration,
regarding the R2 and RMSECV (Table 3). The similarities
between the PLS models’ performance (concerning R2 and
RMSECV) for cultures S and A1 are according to growth
similarities between these cultures, whereas culture A2
showing a different growth profile yielded a different PLS
models performance. The similarities between PLS models
for culture S and A1 and the differences between these cul-
tures and culture A2 are also reflected in the regression vec-
tors of the corresponding PLS models (Figure 3). For
example, the region between 2800 and 3800 cm21 shows a
contribution to the PLS models for glucose, lactate and
ammonia of cultures S and A1, as opposed to culture A2.
This region reflects mostly stretching vibrations between X-
H groups (where X is C, O or N), present e.g., in hydroxyl
groups on glucose, lactate, and NH on ammonia. Therefore,
the present PLS model performances may be dependent of
the expansion process characteristics.
All PLS models from the three cultures had a strong con-
tribution from the spectral region between 500 and
1900 cm21. The region between 1800 and 1500 cm21
reflects mainly stretching vibrations of double bonds between
C@X, where X is C, O or N), e.g. C@O present in the alde-
hyde group of glucose and in the carboxylic group of lactic
acid. The region between 1500 and 500 cm21 reflects a vari-
ety of overlapped vibrations, being designated as the finger-
printing region.47 The strong contribution of this region for
the PLS models developed for glucose, lactate and ammonia
most probably reflects the effect of the stem cells metabo-
lism on the culture medium matrix.
One factor that must be taken into account when evaluat-
ing PLS models for different parameters while studying a
cell culture, is that some of these parameters are highly cor-
related with each other (for instance lactate is a product of
glucose fermentation). The different feeding conditions and
microcarriers applied to the culture runs can be very useful
to break the correlations between the compounds under
study.18,28 Also some useful information can be obtained
through the PLS regression vector, as it provides information
about the spectral regions that contribute the most for model
building. The regression vectors obtained for glucose and
lactate are more similar compared to the regression vector
obtained from the ammonia model (Figure 3), as glucose
and lactate have similar molecular compositions, thus
absorbing in similar wavelength regions. Nevertheless, the
PLS models for the three analytes provided distinct regres-
sion vectors.
An additional global PLS model was developed using all
samples from the three independent cultures (176 samples
including replicates), performed under different conditions,
either regarding the type of microcarriers used or the fre-
quency of the medium renewal. This PLS model therefore
accounted for a high variability in terms of culture condi-
tions. Because of the larger number of samples available for
the glucose and lactate model, the calibration and test sets
consisted of samples randomly chosen from the three cul-
tures, where the calibration set included about 2/3 of the
available samples and the test set about 1/3 of the samples.
The ammonia model was built using a LOO cross-validation
strategy as before. When comparing the PLS models using
all available samples with the models developed using a sin-
gle culture, a general decrease in the predictive ability was
Figure 4. Glucose and lactate concentrations predicted by
global PLS regression models, based on MIR spec-
tra obtained from three independent MSC expan-
sion processes, in relation to the reference values
obtained by conventional methods.
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observed, as expected (Figure 4, Table 3). Nevertheless, still
accurate global PLS models were obtained. A glucose model
based on 5 LVs was obtained (Figure 4), yielding a RMSEP
of 0.33 mM and a R2 of 0.95. For the lactate prediction
(Figure 4), a model based on 5 LVs resulted in a RMSEP of
0.57 mM and a R2 of 0.97. These errors obtained by model-
ing MIR spectra from three different cultures are in agree-
ment with previous errors obtained by other authors.16,18,19
The global PLS model obtained for ammonia yielded con-
siderably worse predictions when compared to the PLS mod-
els obtained for each individual culture. A model with 5 LVs
resulted in a RMSECV of 0.70 mM and a R2 of 0.78. As an
attempt to improve the model predictive performance, two
models with selected spectral regions were built: first, using
only the spectral region between 500 and 1900 cm21, as the
regression vector highlights this region as the one with the
highest contribution for model development (Figure 5A);
second, by eliminating the spectral regions between 3500
and 4000 cm21 and between 1950 and 2700 cm21, which
presented a lower contribution for the model development
(Figure 5A). The model using only the spectral region
between 500 and 1900 cm21 showed no improvements,
which may indicate that even showing a lower contribution
to the model, the excluded spectral regions still provide
meaningful information. For the second model, for which
two spectral regions were eliminated, the predictive ability
significantly improved. For this last model based on 5 LVs a
RMSECV of 0.09 mM and a R2 of 0.86 were obtained
(Figure 5B).
In resume, FT-MIR spectroscopy, combined with multi-
variate data analysis, proved to be an ideal tool to monitor-
ing MSCs expansion in bioreactors, as it enables a rapid
estimation of several critical parameters at once, in an
economic and high-throughput way. The knowledge on the
process can therefore be substantially increased in a near
real-time fashion.
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Figure 5. Ammonia global PLS model based on spectral data from the three cultures. (A) Regression vector from the PLS model con-
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ence values obtained by conventional methods.
Biotechnol. Prog., 2015, Vol. 00, No. 00 7
Literature Cited
1. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells:
environmentally responsive therapeutics for regenerative medi-
cine. Exp Mol Med. 2013;45:e54.
2. Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW.
Immunological characteristics of human mesenchymal stem cells
and multipotent adult progenitor cells. Immunol Cell Biol. 2013;
91:32–39.
3. De Miguel MP, Fuentes-Julian S, Blazquez-Martınez A, Pascual
CY, Aller MA, Arias J, Arnalich-Montiel F. Immunosuppressive
properties of mesenchymal stem cells: advances and applica-
tions. Curr Mol Med. 2012;12:574–591.
4. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J.
Same or not the same? Comparison of adipose tissue-derived
versus bone marrow-derived mesenchymal stem and stromal
cells. Stem Cells Dev. 2012; 21:2724–2752.
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak
DR. Multilineage potential of adult human mesenchymal stem
cells. Science. 1999;284:143–147.
6. Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeu-
tics. Annu Rev Biomed Eng. 2010;12:87–117.
7. Bieback K, Schallmoser K, Kl€uter H, Strunk D. Clinical proto-
cols for the isolation and expansion of mesenchymal stromal
cells. Transfus Med Hemother. 2008;35:286–294.
8. dos Santos F, Andrade PZ, Silva CL, Cabral JM. Scaling-up ex
vivo expansion of mesenchymal stem/stromal cells for cellular
therapies. In: Chase LG, Vemuri MC, editors. Mesenchymal
Stem Cell Therapy. Humana Press, New York; 2013;1–14.
9. Rodrigues CA, Fernandes TG, Diogo MM, da silva CL, Cabral
JM. Stem cell cultivation in bioreactors. Biotechnol Adv. 2011;
29:815–829.
10. Kirouac DC, Zandstra PW. The systematic production of cells
for cell therapies. Cell Stem Cell. 2008;3:369–381.
11. Kinzebach S, Bieback K. Expansion of mesenchymal stem/stro-
mal cells under xenogenic-free culture conditions. Adv Biochem
Eng Biotechnol. 2013;129:33–57.
12. Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic
G, Meuleman N, Bron D, Lagneaux L. Isolation of adipose
derived stromal cells without enzymatic treatment: expansion,
phenotypical and functional characterization. Stem Cells Dev.
2014;23:2390–2400.
13. Le Blanc K, Rindgen O. Immunobiology of human mesenchy-
mal stem cells and future use in hematopoietic stem cell trans-
plantation. Biol Blood Marrow Transplant. 2005;1:321–334.
14. Chen AK, Reuveny S, Oh SK. Application of human mesenchy-
mal and pluripotent stem cell microcarrier cultures in cellular
therapy: achievements and future direction. Biotechnol Adv.
2013;31:1032–1046.
15. Hoch AI, Leach JK. Concise review: optimizing expansion of
bone marrow mesenchymal stem/stromal cells for clinical appli-
cations. Stem Cells Transl Med. 2014;3:643–652. doi:10.5966/
sctm.2013-0196.
16. Rhiel M, Ducommum P, Bolzonella I, Marison I, Stockar U.
Real-time in situ monitoring of freely suspended and immobi-
lized cell cultures based on mid-infrared spectroscopic measure-
ments. Biotechnol Bioeng. 2002;77:174–185.
17. Harthun S, Matischak K, Friedl P. Simultaneous prediction of
human antithrombin III and main metabolites in animal cell cul-
ture processes by near-infrared spectroscopy. Biotechnol Techn.
1998;23:393–398.
18. Sandor M, R€udinger F, Bienert R, Grimm C, Solle D, Scheper
T. Comparative non-invasive monitoring via infrared spectros-
copy for mammalian cell cultivations. J Biotechnol. 2013;68:
636–645.
19. Sellick CA, Hansen R, Jarvis RM, Maqsood AR, Stephens GM,
Dickson AJ, Goodacre R. Rapid monitoring of recombinant anti-
body production by mammalian cell cultures using Fourier
transform infrared spectroscopy and chemometrics. Biotechnol
Bioeng. 2010;106:432–442.
20. Rhiel MH, Amrhein MI, Marison IW, von Stockar U. The influ-
ence of correlated calibration samples on the prediction per-
formance of multivariate models based on mid-infrared spectra
of animal cell cultures. Anal Chem. 2002;74:5227–5236.
21. Hakemeyera C, Straussa U, Werza S, Joseb GE, Folque F,
Menezes JC. At-line NIR spectroscopy as effective PAT moni-
toring technique in Mab cultivations during process develop-
ment and manufacturing. Talanta. 2012;90:12–21.
22. Chen Z, Lovett D, Morris J. Process analytical technologies and
real time process control a review of some spectroscopic issues
and challenges. J Process Control. 2011;21:1467–1482.
23. Roggo Y, Chalus P, Maurer L, Lema-Martinez C, Edmond A,
Jent N. A review of near infrared spectroscopy and chemomet-
rics in pharmaceutical technologies. J Pharma Biomed Anal.
2007;44:683–700.
24. Cervera AE, Petersen N, Lantz AE, Larsen A, Gernaey KV.
Application of near-infrared spectroscopy for monitoring and
control of cell culture and fermentation. Biotechnol Prog. 2009;
25:1561–1581.
25. Landgrebe D, Haake C, H€opfner T, Beutel S, Hitzmann B,
Beutel S, Hitzmann B, Scheper TM, Reardon KF. On-line infra-
red spectroscopy for bioprocess monitoring. Appl Microbiol Bio-
technol. 2010;88:11–22.
26. Roychoudhury P, Harvey LM, McNeil B. The potential of mid
infrared spectroscopy (MIRS) for real time bioprocess monitor-
ing. Anal Chim Acta. 2006;571:159–166.
27. Clavaud M, Roggo Y, Von Daeniken R, Liebler A, Schwabe
JO. Chemometrics and in-line near infrared spectroscopic moni-
toring of a biopharmaceutical Chinese hamster ovary cell cul-
ture: prediction of multiple cultivation variables. Talanta. 2013;
111:28–38.
28. Petiot E, Bernard-Moulin P, Magadoux T, Geny C, Pinton H,
Marc A. In-situ quantification of microcarrier animal cultures
using near-infrared spectroscopy. Process Biochem. 2010;45:
1832–1836.
29. Card C, Hunsaker B, Smith T, Hirsch J. Near-infrared spectros-
copy for rapid, simultaneous monitoring. BioProcess Int. 2008;
6:59–67.
30. Harthun S, Matischak K, Friedl P. Determination of recombi-
nant protein in animal cell culture supernatant by near-infrared
spectroscopy. Anal Biochem. 1997;251:73–78.
31. Sales KC, Rosa F, Sampaio PN, Fonseca LP, Lopes MB,
Calado CRC. In situ near-infrared (NIR) versus high-throughput
mid-infrared (MIR) spectroscopy to monitor biopharmaceuticals
production. J Appl Spectrosc 2015;69:760–72.
32. Scholz T, Lopes VV, Calado CRC. High-throughput analysis of
the plasmid bioproduction process in Escherichia coli by FTIR
spectroscopy. Biotechnol Bioeng. 2012;109:2279–2285.
33. Abu-Absi NR, Kenty BM, Cuellar ME, Borys MC, Sakhamuri
S, Strachan DJ, Hausladen MC, Li ZJ. Real time monitoring of
multiple parameters in mammalian cell culture bioreactors using
an in-line Raman spectroscopy probe. Biotechnol Bioeng. 2011;
108:1215–1221.
34. Moretto J, Smelko JP, Cuellar M, Berry B, Doane A, Ryll T,
Wiltberger K. Process Raman spectroscopy for in-line CHO cell
culture monitoring. Am Pharm Rev. 2011;5:18–25.
35. Whelan J, Craven S, Gennon B. In situ spectroscopy for simul-
taneous monitoring of multiple process parameters in mamma-
lian cell culture bioreactors. Biotechnol Prog. 2012;28:1355–
1362.
36. Teixeira AP, Oliveira R, Alves PM, Carrondo MJT. Advan-
ces in on-line monitoring and control of mammalian cell cul-
tures: supporting the PAT initiative. Biotechnol Adv. 2009;
27:726–732.
37. Ren M, Arnold MA. Comparison of multivariate calibration
models for glucose, urea, and lactate from near-infrared and
Raman spectra. Anal Bioanal Chem. 2007;387:879–888.
38. dos Santos F, Andrade PZ, Boura JS, Abecasis MMA, da Silva
CL, Cabral JMS. Ex vivo expansion of human mesenchymal
stem cells: a more effective cell proliferation kinetics and
metabolism under hypoxia. J Cell Physiol. 2010;223:27–35.
39. Sart S, Agathos SN, Li Y. Process engineering of stem cell
metabolism for large scale expansion and differentiation in bio-
reactors. Biochem Eng J. 2014;84:74–82.
40. dos Santos FD, Andrade PZ, Abecasis MM, Gimble JM, Chase
LG, Campbell AM, Boucher S, Vemuri MC, Silva CL, Cabral
JM. Toward a clinical-grade expansion of mesenchymal stem
cells from human sources: a microcarrier-based culture system
8 Biotechnol. Prog., 2015, Vol. 00, No. 00
under xeno-free conditions. Tissue Eng C Methods. 2011;17:
1201–1210.
41. Schop D, Janssen FW, van Rijn LD, Fernandes H, Bloem RM,
de Bruijn JD, van Dijkhuizen-Radersma R. Growth, metabolism,
and growth inhibitors of mesenchymal stem cells. Tissue Eng A.
2009;15:1877–1886.
42. Carmelo JG, Fernandes-Platzgummer A, Diogo MM, da Silva
CL, Cabral JMS. A xeno-free microcarrier-based stirred cul-
ture system for the scalable expansion of human mesenchy-
mal stem/stromal cells isolated from bone marrow and
adipose tissue. Biotechnol J. 2015;10:1235–1247. doi:
10.1002/biot. 201400586
43. Abdi H. Partial least squares regression and projection on latent
structure regression (PLS Regression). Wiley Interdiscip Rev
Comput Stat. 2010;2:387–515.
44. Helland S, Naes T, Isaksson T. Related version of multiplicative
scatter correction method for preprocessing spectroscopic data.
Chemometr Intell Lab Syst. 1995;9:233–241.
45. Haaland DM, Thomas EV. Partial least-squares methods for
spectral analysis. 1. Relation to other quantitative calibration
methods and the extraction of qualitative information. Anal
Chem. 1988;60:1193–1202.
46. Capito F, Zimmer A, Skudas R. Mid-infrared spectroscopy-
based analysis of mammalian cell culture parameters. Biotechnol
Prog. 2015;31:578–586.
47. Bellisola G, Sorio C. Infrared spectroscopy and microscopy in
cancer research and diagnosis. Am J Cancer Res. 2012;2:1–21.
Manuscript received Mar. 18, 2015, and revision received Dec. 1,
2015.
Biotechnol. Prog., 2015, Vol. 00, No. 00 9
